Minsky B D, Mies C, Rich T A, Recht A, Chaffey J T
Department of Radiation Therapy, New England Deaconess Hospital, Boston.
J Clin Oncol. 1988 Jan;6(1):106-18. doi: 10.1200/JCO.1988.6.1.106.
In an effort to determine the patterns of failure and survival of colon cancer, a retrospective review of 294 patients who underwent potentially curative surgery at the New England Deaconess Hospital (NEDH) was performed. For the entire group, the 5-year crude survival rate was 68% and the actuarial rate was 80%. Survival decreased with increasing bowel wall penetration by tumor and the presence of lymph node metastasis. Although survival varied with the tumor site, none of the differences was statistically significant. Other variables, including the grade of adenocarcinoma, size, and the type of surgery had a significant impact on survival. Patterns of failure, expressed as the actuarial incidence of first diagnosed failure at 5 years, were examined by stage and site. There was a trend toward increased failure with increasing bowel wall penetration by tumor and the presence of lymph node metastasis. Abdominal failure, either as the only site or as a component of failure, was the most common type of failure. When compared by site, patients with cecal carcinoma had a significantly lower incidence of local and distant failure than patients with disease in other selected sites. No differences in patterns of failure were seen in patients with carcinomas in the mobile sections of the colon compared with those who had disease arising in the nonmobile sections of the colon. These data may be useful in identifying those patients who might benefit most from adjuvant therapy.
为了确定结肠癌的失败模式和生存率,我们对在新英格兰女执事医院(NEDH)接受了可能治愈性手术的294例患者进行了回顾性研究。对于整个研究组,5年粗生存率为68%,精算生存率为80%。生存率随着肿瘤肠壁浸润深度增加和淋巴结转移的出现而降低。尽管生存率因肿瘤部位而异,但这些差异均无统计学意义。其他变量,包括腺癌分级、大小和手术类型,对生存率有显著影响。失败模式,以5年时首次诊断失败的精算发生率表示,按分期和部位进行了检查。随着肿瘤肠壁浸润深度增加和淋巴结转移的出现,失败有增加的趋势。腹部失败,无论是作为唯一部位还是作为失败的一个组成部分,是最常见的失败类型。按部位比较时,盲肠癌患者的局部和远处失败发生率显著低于其他选定部位疾病的患者。与结肠癌非活动段发生疾病的患者相比,结肠癌活动段发生疾病的患者在失败模式上没有差异。这些数据可能有助于识别那些可能从辅助治疗中获益最大的患者。